Lithium inhibits carcinoid cell growth in vitro

American Journal of Translational Research

Volumn 2, Issue 3, 2010, Pages 248-253

  Greenblatt, David Yu ^a   Ndiaye, Mary ^a   Chen, Herbert ^a   Kunnimalaiyaan, Muthusamy ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Achaete scute complex like 1; BON cells; Carcinoid tumors; Chromogranin A; H727 cells; Lithium chloride; Neuroendocrine tumors; Serotonin

Indexed keywords

CHROMOGRANIN A; GLYCOGEN SYNTHASE KINASE 3; LITHIUM CHLORIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 2; SEROTONIN;

APOPTOSIS; ARTICLE; BIPOLAR DISORDER; CANCER CELL; CANCER INHIBITION; CARCINOID; CELL PROLIFERATION; COMPETITIVE INHIBITION; DOSE RESPONSE; DRUG EFFECT; DRUG SAFETY; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; TUMOR GROWTH; WESTERN BLOTTING;

EID: 77954662891     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology 2005; 128(6):1717-1751.
2. Modlin IM, Champaneria MC, Chan AK, Kidd M. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress. Am J Gastroenterol 2007; 102 (7):1464-1473.
3. Lal A, Chen H. Treatment of advanced carcinoid tumors. Curr Opin Oncol 2006; 18(1):9-15.
4. Pinchot SN, Holen K, Sippel RS, Chen H. Carcinoid tumors. Oncologist 2008; 13(12):1255-1269.
5. Sippel RS, Chen H. Carcinoid tumors. Surg Oncol Clin N Am 2006; 15(3):463-478.
6. Kunnimalaiyaan M, Yan S, Wong F, Zhang YW, Chen H. Hairy Enhancer of Split-1 (HES-1), a Notch1 effector, inhibits the growth of carcinoid tumor cells. Surgery 2005; 138(6):1137-1142.
7. Kunnimalaiyaan M, Traeger K, Chen H. Conservation of the Notch1 signaling pathway in gastrointestinal carcinoid cells. Am J Physiol Gastrointest Liver Physiol 2005; 289(4):G636-G642.
8. Kunnimalaiyaan M, Chen H. The Raf-1 pathway: a molecular target for treatment of select neuroendocrine tumors? Anticancer Drugs 2006; 17 (2):139-142.
9. Kunnimalaiyaan M, Vaccaro AM, Ndiaye MA, Chen H. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells. Mol Cancer Ther 2007; 6(3):1151-1158.
10. Kunnimalaiyaan M, Ndiaye M, Chen H. Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways. Surgery 2007; 142(6):959-964.
11. Pinchot SN, Pitt SC, Sippel RS, Kunnimalaiyaan M, Chen H. Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumors. Curr Opin Investig Drugs 2008; 9(6):576-582.
12. Sippel RS, Carpenter JE, Kunnimalaiyaan M, Lagerholm S, Chen H. Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells. Am J Physiol Gastrointest Liver Physiol 2003; 285(2):G245-G254.
13. Van Gompel JJ, Kunnimalaiyaan M, Holen K, Chen H. ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells. Mol Cancer Ther 2005; 4(6):910-917.
14. Cade JF. Lithium salts in the treatment of psychotic excitement. Med J Aust 1949; 2(10):349-352.
15. Cade JF. Recent advances in the use of lithium. Aust N Z J Psychiatry 1971; 5(1):3-4.
16. Cade JF. Lithium--when, why and how? Med J Aust 1975; 1(22):684-686.
17. McIntyre RS, Mancini DA, Parikh S, Kennedy SH. Lithium revisited. Can J Psychiatry 2001; 46 (4):322-327.
18. Ougolkov AV, Fernandez-Zapico ME, Savoy DN, Urrutia RA, Billadeau DD. Glycogen synthase kinase-3beta participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells. Cancer Res 2005; 65(6):2076-2081.
19. Ougolkov AV, Fernandez-Zapico ME, Bilim VN, Smyrk TC, Chari ST, Billadeau DD. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation. Clin Cancer Res 2006; 12(17):5074-5081.
20. Mazor M, Kawano Y, Zhu H, Waxman J, Kypta RM. Inhibition of glycogen synthase kinase-3 represses androgen receptor activity and prostate cancer cell growth. Oncogene 2004; 23 (47):7882-7892.
21. Shakoori A, Mai W, Miyashita K, Yasumoto K, Takahashi Y, Ooi A et al. Inhibition of GSK-3beta activity attenuates proliferation of human colon cancer cells in rodents. Cancer Sci 2007.
22. Dong J, Peng J, Zhang H, Mondesire WH, Jian W, Mills GB et al. Role of glycogen synthase kinase 3beta in rapamycin-mediated cell cycle regulation and chemosensitivity. Cancer Res 2005; 65 (5):1961-1972.
23. Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1996; 93(16):8455-8459.